SNTI Senti Biosciences, Inc.
Healthcare$0.99+0.28%ClosedMarket Cap: $25.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
11.92
P/S
682.80
EV/EBITDA
-0.68
DCF Value
$-0.07
FCF Yield
-142.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
-6134.2%
Operating Margin
-154810.5%
Net Margin
-135650.0%
ROE
-503.8%
ROA
-134.8%
ROIC
-197.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $16.0K | 100.0% | $-11.5M | $-4.2M | $— | — |
| Q4 null | $22.0K | -3959.1% | $-13.6M | $-14.5M | $— | — |
| FY null | $22.0K | -16431.8% | $-63.7M | $-61.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-16.9M | $-18.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-16.8M | $-14.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-16.4M | $-14.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-16.2M | $-610.0K | $— | — |
| FY null | $0.00 | NaN% | $-61.0M | $-52.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.2M | $-28.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-13.4M | $-11.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-16.3M | $-12.1M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-18.4M | $-18.7M | $-4.16 | — |